Abbreviated Versus Standard Dual Antiplatelet Therapy Times After Percutaneous Coronary Intervention in Patients With High Bleeding Risk With Acute Coronary Syndrome: Insights From the SWEDEHEART Registry.
Anton HåkanssonSasha KoulElmir OmerovicJonas AnderssonStefan K JamesStefan AgewallArash MokhtariJesper van Der PalsAxel WesterKarolina Elisabeth SzummerTomas JernbergDavid ErlingeMoman Aladdin MohammadPublished in: Journal of the American Heart Association (2024)
In patients with HBR undergoing percutaneous coronary intervention due to acute coronary syndrome, abbreviated DAPT was associated with comparable rates of net adverse clinical events and major adverse cardiovascular events to a DAPT duration of 12 months.
Keyphrases
- antiplatelet therapy
- acute coronary syndrome
- percutaneous coronary intervention
- cardiovascular events
- coronary artery disease
- st segment elevation myocardial infarction
- acute myocardial infarction
- st elevation myocardial infarction
- coronary artery bypass grafting
- cardiovascular disease
- atrial fibrillation
- coronary artery bypass
- adverse drug